ea0016p372 | Growth factors | ECE2008
Friedrich Nele
, Nonnenberg Dennis
, Spilcke-Liss Elisabeth
, Volzke Henry
, Dorr Marcus
, Wallaschofski Henri
Background: Acromegaly is associated with increased morbidity and mortality from cardiovascular disease. Several studies indicate that reduction of growth hormone (GH) to <1 μg/l or normalization of serum IGF-I reduces mortality to expected levels. Inflammatory markers, such as C-reactive protein (CRP) or haemostatic markers, such as fibrinogen have emerged as important cardiovascular risk markers in the general population.Objective and design: ...